These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 23912800)
1. Regulatory T cells in Behçet's disease: is there a correlation with disease activity? Does regulatory T cell type matter? Gündüz E; Teke HU; Bilge NS; Cansu DU; Bal C; Korkmaz C; Gülbaş Z Rheumatol Int; 2013 Dec; 33(12):3049-54. PubMed ID: 23912800 [TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ regulatory T cells in patients with Behçet's disease. Hamzaoui K; Hamzaoui A; Houman H Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S71-8. PubMed ID: 17067431 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations. Pekiner FN; Aytugar E; Demirel GY; Borahan MO J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625 [TBL] [Abstract][Full Text] [Related]
4. Low expressions of PD-L1 and CTLA-4 by induced CD4 Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334 [TBL] [Abstract][Full Text] [Related]
5. Induction of regulatory T cells by infliximab in Behcet's disease. Sugita S; Yamada Y; Kaneko S; Horie S; Mochizuki M Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):476-84. PubMed ID: 20861484 [TBL] [Abstract][Full Text] [Related]
6. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model. Shim J; Lee ES; Park S; Bang D; Sohn S Cytotherapy; 2011 Aug; 13(7):835-47. PubMed ID: 21506890 [TBL] [Abstract][Full Text] [Related]
7. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells. Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820 [TBL] [Abstract][Full Text] [Related]
8. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4 Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845 [TBL] [Abstract][Full Text] [Related]
9. The relation of CD4 Kamal M; Gabr H; Anwar S; Bastawy S; Salah L Lupus; 2022 Apr; 31(4):463-471. PubMed ID: 35249399 [TBL] [Abstract][Full Text] [Related]
10. Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome. Dal Ben ER; do Prado CH; Baptista TS; Bauer ME; Staub HL J Clin Immunol; 2013 May; 33(4):876-9. PubMed ID: 23354908 [TBL] [Abstract][Full Text] [Related]
11. Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. Bhattacharya K; Chandra S; Mandal C Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800 [TBL] [Abstract][Full Text] [Related]
12. 2-Gy whole-body irradiation significantly alters the balance of CD4+ CD25- T effector cells and CD4+ CD25+ Foxp3+ T regulatory cells in mice. Qu Y; Zhang B; Liu S; Zhang A; Wu T; Zhao Y Cell Mol Immunol; 2010 Nov; 7(6):419-27. PubMed ID: 20871628 [TBL] [Abstract][Full Text] [Related]
13. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression]. Chen YL; Chen XR; Qin LX; Yang YF; Tang YM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412 [TBL] [Abstract][Full Text] [Related]
14. sCTLA-4, CD4+CD25+Foxp3+ regulatory T cells in Behçet's disease patients. Demir N; Ilhan F; Demir T; Godekmerdan A Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S116-7. PubMed ID: 23010434 [No Abstract] [Full Text] [Related]
15. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients. Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292 [TBL] [Abstract][Full Text] [Related]
16. Subpopulations of regulatory T cells in rheumatoid arthritis, systemic lupus erythematosus, and Behcet's disease. Kim JR; Chae JN; Kim SH; Ha JS J Korean Med Sci; 2012 Sep; 27(9):1009-13. PubMed ID: 22969245 [TBL] [Abstract][Full Text] [Related]
17. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650 [TBL] [Abstract][Full Text] [Related]
18. Elevated Circulating CD4 Hu X; Gu Y; Zhao S; Hua S; Jiang Y Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076 [No Abstract] [Full Text] [Related]
19. Role of regulatory CD4+CD25+ Foxp3 T cells in bronchial asthma in Egyptian children. Bakr SI; Mahran MZ; Soliman DA Egypt J Immunol; 2013; 20(2):29-38. PubMed ID: 24617045 [TBL] [Abstract][Full Text] [Related]
20. Aberrant peripheral blood CD4 Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]